Biotech stocks are ready to break out. They just need one more thing

Biotech stocks tend to outperform in the months leading up to an interest rate cut. But other factors are driving performance too.

Related Keywords

,Pfizer ,Drug Administration ,Bristol Myers Squibb ,Group Fedwatch ,Morgan Stanley ,Rhythm Pharmaceuticals ,Phathom Pharmaceuticals ,Rocket Pharmaceuticals ,Federal Reserve ,Fed Funds ,Wall Street ,Nasdaq Biotechnology Index ,Joseph Stringer ,Rare Disease ,Phathom Pharmaceutical ,New Jersey Based ,Intellia Therapeutics ,Health Care Industry ,Biotech And Pharmaceuticals ,Rocket Pharmaceuticals Inc ,Intellia Therapeutics Inc ,Merck Amp Co Inc ,Pfizer Inc ,Bristol Myers Squibb Co ,Abbvie Inc ,Rhythm Pharmaceuticals Inc ,Vaxcyte Inc ,Phathom Pharmaceuticals Inc ,Investment Strategy ,Business News ,